The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of neoadjuvant systemic therapy given during window trials on quality metrics in resectable head and neck squamous cell carcinoma.
 
Marco Antonio Mascarella
No Relationships to Disclose
 
Varun Vendra
No Relationships to Disclose
 
Mark Kubik
No Relationships to Disclose
 
Shaum Sridharan
No Relationships to Disclose
 
Seungwon Kim
No Relationships to Disclose
 
Robert L. Ferris
Stock and Other Ownership Interests - Novasenta
Consulting or Advisory Role - Aduro Biotech; Bristol-Myers Squibb; EMD Serono; Macrogenics; Merck; Novasenta; Numab; Pfizer; Sanofi; Zymeworks
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck; Novasenta; Tesaro
 
Moon Jung Fenton
No Relationships to Disclose
 
James Ohr
No Relationships to Disclose
 
Dan Paul Zandberg
Research Funding - Aduro Biotech (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Exelixis (Inst); MacroGenics (Inst); Merck (Inst)
 
Umamaheswar Duvvuri
No Relationships to Disclose